Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 15 INDUSTRY 7 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Specimen Handling 47 Magnetic Resonance Spectroscopy 38 Cyclophosphamide 28 Vincristine 22 Radiation 19 Dexamethasone 19 Etoposide 18 Cisplatin 18 Carboplatin 17 Biopsy 17 Radiotherapy 16 Doxorubicin 13 Cytarabine 13 daratumumab 12 Leucovorin 12 Methotrexate 11 Gemcitabine 11 X-Rays 10 Standard of Care 10 Platinum 10 Docetaxel 10 durvalumab 9 Rituximab 9 Radiotherapy, Intensity-Modulated 9 Prednisone 9 Practice Guidelines as Topic 9 Calcium Dobesilate 9 1,2-diaminocyclohexaneplatinum II citrate 9 merphos 8 dexamethasone acetate 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Axitinib × 90 days × Clear all

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡